Abstract: Giant cell tumor is a rare non-odontogenic lesion that represents approximately 4-5% of all primary bone tumors. Such lesions derive their actual name from the constant presence of numerous giant cells, similar to osteoclasts. All the giant cell tumors hystorically is treated with curettage. Because this conservative approach is often associated with a recurrence rate of up to 70%, aggressive resection has become the standard practice. Unfortunately, recurrence after wide resection is about 7%. The aim of the study is to describe the 14 years single institution experience with management of primary non-aggressive giant cell tumor of the jaws bone.